Health Rounds: Old anti-inflammatory may delay colon cancer recurrence
Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
Science Daily4d
Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence
Evidence has since emerged suggesting that anti-inflammatory drugs might benefit some patients with colon cancer, but not others. One possibility for this is that patients who have a blood test ...
Healthline22d
How Untreated Crohn’s Can Be Fatal
Crohn’s disease is a type of inflammatory bowel disease (IBD ... individuals with IBD are at a higher risk of developing colorectal cancer, or cancer in the lining of the colon or rectum.
Medical Xpress17d
Colorectal cancer treatment: New therapy could be achieved by blocking DUSP6 protein
Colorectal cancer (CRC ... at research to further understand the pathogenesis of CRC, and to develop DUSP6 targeted therapies for treatment of the cancer, to improve health outcomes for patients.
Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence
A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...